Ceftazidime Dosing for Severe Pneumonia and Cystic Fibrosis Patients
Adult Severe Hospital‑Acquired Pneumonia
Evidence: Clinical study (American Journal of Respiratory and Critical Care Medicine, 2005)
Cystic Fibrosis (CF) Dosing Recommendations
Evidence: European Respiratory Society consensus (European Respiratory Journal, 2000)
CF‑Specific Administration Considerations
Ceftazidime Dosing Considerations for Severe Infections
Special Considerations for Severe Infections
- For carbapenem-resistant Pseudomonas aeruginosa susceptible to ceftazidime, the American College of Physicians recommends using 2 grams IV every 8 hours for 5-14 days (longer courses of 10-14 days for pneumonia and bloodstream infections) 4
- The Infectious Diseases Society of America found that intravenous ciprofloxacin was more cost-effective compared to IV ceftazidime in patients who had not received quinolone prophylaxis, with a moderate strength of evidence 5, 6
Monitoring and Safety
- The American Academy of Neurology recommends monitoring for neurotoxicity (seizures, encephalopathy, confusion), particularly in patients with renal impairment where drug accumulation can occur, with a high strength of evidence 7